MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
This Quarter Return
-2.49%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$12.8B
AUM Growth
+$12.8B
(-6.5%)
Cap. Flow
-$361M
Cap. Flow
% of AUM
-2.81%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
339
Reduced
990
Closed
147
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$36.4M |
| 2 |
Blackstone
BX
|
$17.3M |
| 3 |
Airbnb
ABNB
|
$13.3M |
| 4 |
Kenvue
KVUE
|
$9.06M |
| 5 |
Civitas Resources
CIVI
|
$7.64M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
$125M |
| 2 |
Accenture
ACN
|
$57.6M |
| 3 |
Medtronic
MDT
|
$26.2M |
| 4 |
Apple
AAPL
|
$19.8M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$18.4M |
Sector Composition
| 1 | Technology | 25.14% |
| 2 | Healthcare | 12.02% |
| 3 | Financials | 11.49% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
AT&T
T
$208B
| $26.6M | 0.21% |
1,768,528
-46,265
| -3% | -$695K |
|
77
Lockheed Martin
LMT
$105B
| $26.5M | 0.21% |
64,903
-1,748
| -3% | -$715K |
|
78
Marsh & McLennan
MMC
$101B
| $26.4M | 0.21% |
138,721
-3,376
| -2% | -$642K |
|
79
Goldman Sachs
GS
$221B
| $26.3M | 0.21% |
81,411
-2,782
| -3% | -$900K |
|
80
Elevance Health
ELV
$72.4B
| $26M | 0.2% |
59,631
-1,854
| -3% | -$807K |
|
81
RTX Corp
RTX
$212B
| $25.9M | 0.2% |
360,137
-10,737
| -3% | -$773K |
|
82
Morgan Stanley
MS
$237B
| $25.7M | 0.2% |
314,124
-14,537
| -4% | -$1.19M |
|
83
Prologis
PLD
$103B
| $25.6M | 0.2% |
228,491
-5,887
| -3% | -$661K |
|
84
Vertex Pharmaceuticals
VRTX
$102B
| $25.6M | 0.2% |
73,654
-1,544
| -2% | -$537K |
|
|
85
SPDR S&P MidCap 400 ETF Trust
MDY
$23.6B
| $24.6M | 0.19% |
53,900
-40,200
| -43% | -$18.4M |
|
86
Lam Research
LRCX
$124B
| $24M | 0.19% |
382,830
-11,080
| -3% | -$694K |
|
87
Stryker
SYK
$149B
| $24M | 0.19% |
87,709
-2,149
| -2% | -$587K |
|
88
Mondelez International
MDLZ
$79.3B
| $23.4M | 0.18% |
336,488
-9,142
| -3% | -$634K |
|
89
Zoetis
ZTS
$67.6B
| $23.2M | 0.18% |
133,197
-3,399
| -2% | -$591K |
|
90
Gilead Sciences
GILD
$140B
| $23.1M | 0.18% |
308,279
-8,376
| -3% | -$628K |
|
91
Progressive
PGR
$145B
| $22.7M | 0.18% |
163,005
-3,794
| -2% | -$529K |
|
92
American Express
AXP
$225B
| $22.7M | 0.18% |
152,190
-6,758
| -4% | -$1.01M |
|
93
Blackrock
BLK
$170B
| $22.6M | 0.18% |
34,882
-3,111
| -8% | -$2.01M |
|
94
CVS Health
CVS
$93B
| $22.2M | 0.17% |
317,619
-7,756
| -2% | -$542K |
|
95
American Tower
AMT
$91.9B
| $22.1M | 0.17% |
134,691
-2,992
| -2% | -$492K |
|
|
96
Blackstone
BX
$131B
| $22M | 0.17% |
205,306
+161,927
| +373% | +$17.3M |
|
97
Regeneron Pharmaceuticals
REGN
$59.8B
| $21.9M | 0.17% |
26,635
-961
| -3% | -$791K |
|
98
Analog Devices
ADI
$120B
| $21.7M | 0.17% |
124,107
-4,284
| -3% | -$750K |
|
99
Cigna
CI
$80.2B
| $21.2M | 0.17% |
74,032
-1,890
| -2% | -$541K |
|
100
Chubb
CB
$111B
| $21.2M | 0.16% |
101,624
-3,464
| -3% | -$721K |
|